Not applicableStudy completedNCT02200705What this trial is testingCryoablation of Low Risk Small Breast Cancer- ICE3 TrialWho this might be right forBreast Cancer IceCure Medical Ltd. 206
Testing effectiveness (Phase 2)Study completedNCT00941330What this trial is testingExemestane or Docetaxel-Cytoxan in Low Recurrence Score CancersWho this might be right forBreast Cancer Emory University 31
Testing effectiveness (Phase 2)Active Not RecruitingNCT05165225What this trial is testingPhase II Neoadjuvant Pyrotinib Combined With Neoadjuvant Chemotherapy in HER2-low-expressing and HR Positive Early or Locally Advanced Breast Cancer: a Single-arm, Non-randomized, Single-center, Open Label TrialWho this might be right forBreast CancerHER2-low-expressing Breast CancerHormone Receptor-positive Breast Cancer+1 more Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 48
Not applicableLooking for participantsNCT04278469What this trial is testingClinical High and Genomic Low Hormone Receptor-positive Early Breast Cancer Patients With or Without Adjuvant ChemotherapyWho this might be right forEarly Hormone Receptor-positive Breast Cancer Gencurix, Inc. 194
Not applicableActive Not RecruitingNCT07462351What this trial is testingSystem-integrated Point-of-Care Ultrasound in Breast Cancer ScreeningWho this might be right forBreast Cancer Region Skane 4,800
Testing effectiveness (Phase 2)Study completedNCT01432145What this trial is testingA Clinical Trial in Patients With Breast Cancer Susceptibility Gene (BRCA) Defective TumoursWho this might be right forBreast CancerOvarian Cancer University of Oxford 74
Not applicableStudy completedNCT05989022What this trial is testingComparison of Low-dose Spiral Breast CT With MRI in Major Indications of MRI for Breast DiagnosticsWho this might be right forBreast Cancer Diagnosis AB-CT - Advanced Breast-CT GmbH 293
Testing effectiveness (Phase 2)UnknownNCT04004910What this trial is testingA Study Comparing Immunopheresis® Alone or In Combination With Chemotherapy Versus Chemotherapy Alone in Treatment of Advanced Breast Cancer PatientsWho this might be right forAdvanced Breast Cancer Immunicom Inc 170
Testing effectiveness (Phase 2)Looking for participantsNCT07817082What this trial is testingPhase II Study of SHR-A1811 for Ultra-Low HER2 Advanced Breast CancerWho this might be right forAdvanced Breast Cancer With Ultra-Low HER2 Expression Tianjin Medical University Cancer Institute and Hospital 30
Not applicableStudy completedNCT05754047What this trial is testingTumor Characteristics and Survival Rate of HER2-Low Breast Cancer PatientsWho this might be right forHER2 Low Breast Carcinoma Mahdis Bayat 3,582
Testing effectiveness (Phase 2)UnknownNCT02829008What this trial is testingLow -Dose-bevacizumab and Pemetrexed Versus TPC in Metastatic HER2-negative Breast Cancer PatientsWho this might be right forMetastatic Breast Cancer Chinese Academy of Medical Sciences 120
Very early researchLooking for participantsNCT07608848What this trial is testingFirst-in-human Diagnostic Imaging Profile of the Theranostic Pair [68Ga]Ga-DOTA-STR-17126 and Low Dose [177Lu] Lu-DOTA-STR-17126 in Patients With Advanced or Metastatic CancerWho this might be right forMetastatic Breast CancerMetastatic Prostate CancerGRPR-Targeted Molecular Imaging+5 more Integrated Haematology and Oncology Network 20
Large-scale testing (Phase 3)Active Not RecruitingNCT03488693What this trial is testingRegional Radiotherapy in Biomarker Low-Risk Node Positive and T3N0 Breast CancerWho this might be right forBreast Cancer Canadian Cancer Trials Group 2,138
Not applicableStudy completedNCT01727011What this trial is testingSingle Fraction Elderly Breast Irradiation (SiFEBI)Who this might be right forBreast Cancer Centre Antoine Lacassagne 37
Testing effectiveness (Phase 2)Ended earlyNCT00726180What this trial is testingUse of Trastuzumab to Induce Increased ER Expression in ER-negative/Low, Her-2/Neu Positive Breast CancerWho this might be right forBreast Cancer University of Michigan Rogel Cancer Center 1
Not applicableStudy completedNCT01925170What this trial is testingLow Dose Molecular Breast Imaging as a Screening Tool for Women With Dense BreastsWho this might be right forBreast Cancer Mayo Clinic 1,638
Testing effectiveness (Phase 2)WithdrawnNCT05967286What this trial is testingOlaparib and Alpelisib for Treatment of Metastatic Breast Cancer, A ComboMATCH Treatment TrialWho this might be right forAnatomic Stage III Breast Cancer AJCC v8Anatomic Stage IV Breast Cancer AJCC v8Metastatic HER2-Negative Breast Carcinoma+1 more National Cancer Institute (NCI)
Testing effectiveness (Phase 2)Looking for participantsNCT06224673What this trial is testingARX788 for Treating Patients With HER2-low Locally Advanced Unresectable or Metastatic Breast CancerWho this might be right forHER2 Low Breast CarcinomaTriple Negative Breast CancerHormone-receptor-positive Breast Cancer+1 more Laura Huppert, MD, BA 36
Not applicableLooking for participantsNCT06711055What this trial is testingTaxane Combined Targeted Therapy for Low-risk HER2 Positive and Lymph Node Negative Breast CancerWho this might be right forHER2-positive Breast Cancer Shu Wang 285
Testing effectiveness (Phase 2)Looking for participantsNCT07410676What this trial is testingEBNK-001 Allogeneic NK Cells With Low-Dose IL-15 ± Pembrolizumab in Advanced Solid TumorsWho this might be right forCancerSarcomaLeukaemia+12 more Essen Biotech 83